United they go: Conjunct regulation of aortic antioxidant enzymes during atherogenesis

Circulation Research

Volumn 93, Issue 3, 2003, Pages 183-185

  Palinski, Wulf ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Atherosclerosis; Gene expression; Oxidation; Pathophysiology

Indexed keywords

ANTIOXIDANT; ENZYME; REACTIVE OXYGEN METABOLITE;

AORTA ATHEROSCLEROSIS; ATHEROGENESIS; EDITORIAL; ENZYME REGULATION; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADOLESCENT; ANIMALS; ANTIOXIDANTS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHILD; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENZYMES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERCHOLESTEROLEMIA; MACROPHAGES; MICE; MICE, KNOCKOUT; OXIDATION-REDUCTION; OXIDATIVE STRESS; PREGNANCY;

EID: 0042025070     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000087332.75244.42     Document Type: Editorial

References (19)

1. Darley-Usmar V, Halliwell B. Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharmacol Res. 1996;13:649-662.
2. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
3. Steinberg D, Witztum JL. Lipoproteins, lipoprotein oxidation, and atherogenesis. In: Chien KR, ed. Molecular Basis of Cardiovascular Disease. Philadelphia, Pa: WB Saunders; 1999:458-475.
4. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:1876-1890.
5. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol. 1998;10:248-253.
6. Collins T, Cybulsky M. NF-κB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest. 2001;107:255-264.
7. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell. 1998;93:229-240.
8. Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass CK. Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 2000;106:523-531.
9. Sata M, Walsh K. Oxidized LDL activates Fas-mediated endothelial cell apoptosis. J Clin Invest. 1998;102:1682-1689.
10. Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: a mechanistic clue to the response to injury hypothesis. Circulation. 1997;95:1760-1763.
11. Napoli C, Quehenberger O, de Nigris F, Abete P, Glass CK, Palinski W. Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J. 2000;14:1996-2007.
12. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol. 2003;284:R1-R12.
13. Shi W, Wang X, Shih DM, Laubach VE, Navab M, Lusis AJ. Paradoxical reduction of fatty streak formation in mice lacking endothelial nitric oxide synthase. Circulation. 2002;105:2078-2082.
14. 't Hoen PAC, Van der Lans CAC, Van Eck M, Bijsterbosch MK, Van Berkel TJC, Twisk J. Aorta of apoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res. 2003;93:262-269.
15. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J. 2002;16:1348-1360.
16. D'Armiento FP, Bianchi A, de Nigris F, Capuzzi DM, D'Armiento MR, Crimi G, Abete P, Condorelli M, Napoli C. Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke. 2001;32:2472-2480.
17. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol. 2001;158:879-891.
18. Gotto AM. Antioxidants, statins, and atherosclerosis. J Am Coll Cardiol. 2003;41:1205-1210.
19. Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation. 2002;105:2107-2111.